Tropical Health Matters: Malaria, Onchocerciasis, and Ivermectin — Possibility of Eliminating Two Diseases
Bill Brieger, professor in the Department of International Health at Johns Hopkins Bloomberg School of Public Health, discusses the potential synergies of using ivermectin to treat onchocerciasis and prevent malaria. “Because of the need to find new and complementary tools to eliminate malaria the Malaria Policy Advisory Committee (MPAC) of the World Health Organization’s Global Malaria Program considered at its recent meeting the role of ivermectin in the future of malaria control and elimination and the importance of further research,” Brieger notes (10/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.